BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29264937)

  • 61. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
    Sitter T; Schmidt M; Schneider S; Schiffl H
    J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Point-of-care multiplex molecular diagnosis coupled with procalcitonin-guided algorithm for antibiotic stewardship in lower respiratory tract infection: a randomized controlled trial.
    Velly L; Cancella de Abreu M; Boutolleau D; Cherubini I; Houas E; Aurousseau A; Hausfater P
    Clin Microbiol Infect; 2023 Nov; 29(11):1409-1416. PubMed ID: 37549731
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients.
    Cheval C; Timsit JF; Garrouste-Orgeas M; Assicot M; De Jonghe B; Misset B; Bohuon C; Carlet J
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S153-8. PubMed ID: 18470711
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.
    Martinez FJ; Curtis JL
    Chest; 2007 Jan; 131(1):1-2. PubMed ID: 17218546
    [No Abstract]   [Full Text] [Related]  

  • 66. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
    Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
    Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
    Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Survey of serum procalcitonin in cirrhotic patients.
    Rahimkhani M; Einollahi N; Khavari Daneshvar H; Dashti N
    Acta Med Iran; 2013 Apr; 51(3):153-6. PubMed ID: 23605598
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators.
    Christ-Crain M; Müller B
    Eur Respir J; 2007 Sep; 30(3):556-73. PubMed ID: 17766633
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis.
    Schuetz P; Bretscher C; Bernasconi L; Mueller B
    Expert Rev Mol Diagn; 2017 Jun; 17(6):593-601. PubMed ID: 28443360
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Procalcitonin in special patient populations: Guidance for antimicrobial therapy.
    Smith SE; Muir J; Kalabalik-Hoganson J
    Am J Health Syst Pharm; 2020 May; 77(10):745-758. PubMed ID: 32340027
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.
    Long W; Deng X; Zhang Y; Lu G; Xie J; Tang J
    Respirology; 2011 Jul; 16(5):819-24. PubMed ID: 21507143
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19: A Multicenter Observational Cohort Study.
    Hessels LM; Speksnijder E; Paternotte N; van Huisstede A; Thijs W; Scheer M; van der Steen-Dieperink M; Knarren L; van Den Bergh JP; Winckers K; Henry R; Simsek S; Boersma WG;
    Chest; 2023 Sep; 164(3):596-605. PubMed ID: 37116748
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Low-Level Elevations of Procalcitonin Are Associated with Increased Mortality in Acute Heart Failure Patients, Independent of Concomitant Infection.
    Darche FF; Biener M; Müller-Hennessen M; Rivinius R; Stoyanov KM; Milles BR; Katus HA; Frey N; Giannitsis E
    Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947960
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outcome of High Level Procalcitonin (PCT) without Evidence of Infection in Patients with End Stage Renal Disease (ESRD) Accompanied by Abnormal Liver Function: a Case Report.
    Jin M; Liu J; Chen X; Zhao S; Xu C
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255308
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of procalcitonin in acute heart failure patients.
    Möckel M; Searle J; Maisel A
    ESC Heart Fail; 2017 Aug; 4(3):203-208. PubMed ID: 28772049
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Usefulness of serum procalcitonin and point-of-care multiplex PCR gastro-intestinal panel in acute diarrhoea or colitis in the emergency department.
    Cancella de Abreu M; Cassard C; Cherubini I; Houas E; Dechartres A; Hausfater P
    Biomarkers; 2023 Jun; 28(4):396-400. PubMed ID: 36938630
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Biomarker-guided antibiotics prescription for lower respiratory tract infections in primary care : CRP or PCT ?].
    Vingerhoets S; Mueller Y; Pedrazzini B; Boillat-Blanco N; Lhopitallier L
    Rev Med Suisse; 2022 May; 18(781):948-952. PubMed ID: 35543687
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel applications for serum procalcitonin testing in clinical practice.
    Choi JJ; McCarthy MW
    Expert Rev Mol Diagn; 2018 Jan; 18(1):27-34. PubMed ID: 29148856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.